Company: 

About
Dr. Vivaldi is the former President, Chief Executive Officer and Director of Sigilon Therapeutics, a diabetes cell therapy company. Prior to joining Sigilon, Dr. Vivaldi served as Executive Vice President and Chief Global Therapeutics Officer at Bioverativ, Executive Vice President and Chief Commercial Officer at Spark Therapeutics, Chief Executive Officer and Director of Minerva Neurosciences, and, prior to that, held positions of increasing responsibility at Genzyme Corporation.
Personal Details
Title: Dr
Surname: Coelho
M/F: Male
Nationality: American
Country of Birth: United States of America
Language: English
Qualification: MD,MBA
Industry:
Qualifications & Experience
Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:
Other directorships (state)
(only entities turnover at least $5m p/a)
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Viatris | Board | Member | 01/06/2024 | |
| Viatris | Technology | Member | 01/06/2024 |
Independence Questions
Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.